Klara Dickinson-Eason
2015
In 2015, Klara Dickinson-Eason earned a total compensation of $979.7K as SVP, Chief Regulatory Office at Anthera Pharmaceuticals, a 442% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $93,600 |
|---|---|
| Option Awards | $579,720 |
| Salary | $306,411 |
| Total | $979,731 |
Dickinson-Eason received $579.7K in option awards, accounting for 59% of the total pay in 2015.
Dickinson-Eason also received $93.6K in non-equity incentive plan and $306.4K in salary.
Rankings
In 2015, Klara Dickinson-Eason's compensation ranked 8,057th out of 13,638 executives tracked by ExecPay. In other words, Dickinson-Eason earned more than 40.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,057 out of 13,638 | 41st |
Division Manufacturing | 3,065 out of 5,187 | 41st |
Major group Chemicals And Allied Products | 1,110 out of 1,857 | 40th |
Industry group Drugs | 896 out of 1,531 | 42nd |
Industry Pharmaceutical Preparations | 699 out of 1,179 | 41st |
Source: SEC filing on March 16, 2017.
Dickinson-Eason's colleagues
We found three more compensation records of executives who worked with Klara Dickinson-Eason at Anthera Pharmaceuticals in 2015.